Pharma
- The agency’s 2024-25 departmental results report uses rates from a 2021 survey. Newer data is available, but that source doesn’t include rates from all provinces and territories.
- The agency’s 2024-25 departmental results report uses rates from a 2021 survey. Newer data is available, but that source doesn’t include rates from all provinces and territories.
Become a Political Insider
Sign up for Today's Headlines newsletter now
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
- MPs have been on the Hill for less than three months this year thanks to prorogation this past winter and the spring election campaign,
- MPs have been on the Hill for less than three months this year thanks to prorogation this past winter and the spring election campaign,
- MPs have been on the Hill for less than three months this year thanks to prorogation this past winter and the spring election campaign,
- Health Minister Marjorie Michel said something could happen with pan-Canadian licensure for doctors in 2026 but the organization responsible for this work isn’t making
- Health Minister Marjorie Michel said something could happen with pan-Canadian licensure for doctors in 2026 but the organization responsible for this work isn’t making
- Health Minister Marjorie Michel said something could happen with pan-Canadian licensure for doctors in 2026 but the organization responsible for this work isn’t making
- Amid the Liberals’ focus on building a stronger economy, Health Minister Marjorie Michel’s office says that faster access to new medicines and supporting researchers
- Amid the Liberals’ focus on building a stronger economy, Health Minister Marjorie Michel’s office says that faster access to new medicines and supporting researchers
- Amid the Liberals’ focus on building a stronger economy, Health Minister Marjorie Michel’s office says that faster access to new medicines and supporting researchers
- A strong government instills confidence in the country’s people and its businesses. This government's waffling on pharmacare does none of that.
- A strong government instills confidence in the country’s people and its businesses. This government's waffling on pharmacare does none of that.
- A strong government instills confidence in the country’s people and its businesses. This government's waffling on pharmacare does none of that.
- A proactive and co-ordinated strategy from the government is essential to safeguard both access and affordability to medicines for the long term.
- A proactive and co-ordinated strategy from the government is essential to safeguard both access and affordability to medicines for the long term.
- A proactive and co-ordinated strategy from the government is essential to safeguard both access and affordability to medicines for the long term.
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- The Senate Social Affairs, Science, and Technology Committee will have just four weeks to study the pharmacare legislation before its scheduled third reading vote
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- With a current 'hodgepodge' of bills before Parliament, the Liberals may want to form a cohesive narrative through their fall legislative agenda, says Yaroslav
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- The big news in health care these days is national pharmacare. This is surely welcome news for those of us living with any chronic
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients.
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Green Party Leader Elizabeth May and NDP Leader Jagmeet Singh have done their part as responsible opposition critics on this policy. Now it’s Pierre
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Canadians have the chance to consider whether to view access to medicines as a pillar of healthcare, or simply an add-on service.
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
Opinion | April 8, 2024
Opinion | April 8, 2024
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
Opinion | April 8, 2024
- Re: “First phase of pharmacare must not ‘create new gaps’ in existing coverage, says lobbyists (The Hill Times, April 1). I strongly endorse the
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.
- Using insulin is always challenging, so access to a broad range of appropriate options is vital.